Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects

Oncology
0 drugs in development·0 companies·0 clinical trials

Deep-dive into Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects — Drugs in Development & Clinical Trials | BioSniper